Stay updated with breaking news from Wealth Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jumia Technologies AG (NYSE:JMIA – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 9,620,000 shares, a decline of 5.6% from the September 30th total of 10,190,000 shares. Based on an average daily trading volume, of 1,430,000 […]
First Horizon Advisors Inc. lessened its stake in First Trust NASDAQ Rising Dividend Achievers (NASDAQ:RDVY – Free Report) by 40.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 214,162 shares of the company’s stock after selling 142,868 shares during the […]
Valmark Advisers Inc. lessened its stake in shares of First Trust NASDAQ Rising Dividend Achievers (NASDAQ:RDVY – Free Report) by 4.8% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 238,704 shares of the company’s stock after selling 12,068 shares during the quarter. Valmark Advisers Inc.’s holdings in First Trust NASDAQ Rising Dividend Achievers […]
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) was the target of a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 2,030,000 shares, a growth of 28.5% from the September 15th total of 1,580,000 shares. Currently, 1.0% of the company’s shares are sold short. […]
Pfizer (NYSE:PFE – Get Free Report) had its price target cut by research analysts at Citigroup from $42.00 to $35.00 in a research note issued on Monday, Benzinga reports. The firm presently has a “neutral” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 3.80% from the stock’s current price. […]